Kompozycja farmaceutyczna obejmująca (1R,4R)-6'-fluoro-N,N-dimetylo-4-fenylo-4',9'-dihydro-3'H -spiro[cykloheksano-1,1'-pirano[3,4,b]indolo]-4-aminę i paracetamol albo propacetamol
The invention relates to a pharmaceutical composition comprising a first pharmacologically active ingredient selected from (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and the physiologically acceptable salts thereof, and a second pharmacologically active ingredient selected from paracetamol and propacetamol.
